9/21/2026
Ibogaine gains attention for addiction treatment
Psychedelic compound ibogaine draws interest amid regulatory shifts.
Topic archive
marty makary
2 stories
8/19/2026
Trump's FDA pick Overton may boost psychedelics, pain meds
Heidi Overton's nomination could advance psychedelic therapies but raises vaccine concerns.